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Abstract Various symmetrical and unsymmetrical ketones
were successfully coupled with secondary amino acids
in the course of Ugi five-center, four-component reaction
(U-5C-4CR), thus expanding the molecular diversity pos-
sible to be achieved by the reaction. The chemical yields
depended on the degree of hindrance of the components
employed and were satisfactory in view of possible steric
interactions in the U-5C-4CR zwitterionic intermediate.
The sense of diastereoinduction for reactions employing
unsymmetrical ketones was examined by converting the
resulting Ugi adducts into the corresponding rigid 2,6-
diketopiperazine derivatives.
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Introduction
Over the past several decades, multicomponent reactions
(MRCs) have become attractive tools in modern synthetic
organic chemistry. Among their many advantages, they allow
the creation of large chemical libraries of diverse, complex
molecular structures, starting from simple materials within
a short time frame. Not surprisingly, these particular fea-
tures have made MCRs especially appealing to medicinal
chemists [1–6]. The well-known Ugi four-component reac-
tion (U-4CR, Scheme 1) is one of the most widely used
isocyanide-based multicomponent reactions (IMCRs). The
classical variant of U-4CR comprises a one-pot sequential
condensation of an amine, a carbonyl compound, an iso-
cyanide and a carboxylic acid, to produce a linear, peptide-
like adduct with high yield and high atom economy [7–9].
Since its discovery in 1959, the U-4CR has received growing
attention for its potential to quickly assemble complex mole-
cules. Initially, use of U-4CR in this capacity was restricted
by limited availability of various isocyanide components.
Since then, these components, including the so-called ‘con-
vertible’ isocyanides [10–13], have become readily available,
expanding the molecular diversity that can be achieved using
the reaction.
Numerous variants and post-condensation modifications
of the original U-4CR have emerged [14–18]. One of them
is an Ugi five-center four-component reaction (U-5C-4CR,
Scheme 1), which differs from the parent U-4CR not only
in the number of reacting functional groups, but also in
its mechanism. It is based on the condensation of a car-
bonyl compound, an isocyanide, a nucleophile and an amino
acid as a bifunctional component. The reaction is initi-
ated by the reversible formation of the zwitterionic imine
I from the amino acid and carbonyl components. The sub-
sequent addition of the isocyanide and intramolecular addi-
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Scheme 1 Ugi U-4CR and U-5C-4CR
tion of the carboxylate give the cyclic intermediate II, which
undergoes irreversible nucleophilic attack to form the 1,1′-
iminodicarboxylic acid derivative III. It is important to note
that reaction usually proceeds with high diastereoselectivity
if a chiral amino acid is used as an input [19].
Despite its high potential to generate interesting adducts
for medicinal chemistry purposes, U-5C-4CR variant has
received less attention when compared to parent U-4CR. The
reaction has been applied to α- and β-amino acids, alde-
hydes, ketones, isocyanides and simple alcohols [19–25].
However, while ketones have been reported to react suc-
cessfully with primary amino acids in the course of the U-
5C-4CR and related Ugi five-center three component reac-
tion (U-5C-3CR) [21,23,26,27], their condensation with sec-
ondary amino acids has not been explored. Arguably, these
coupling partners can be regarded as insufficiently reactive
because of possible steric interactions in the initial imine
zwitterionic intermediate of the postulated reaction mecha-
nism (Scheme 1). Further, conversely to the condensations of
primary amines or amino acids, in case of secondary amino
acids the imine intermediates can not be preformed.
Recently, we described the application of U-5C-4CR
adducts derived from aldehydes and secondary amino acids
as intermediates for biologically active 2,6-diketopiperazine
(2,6-DKP) derivatives [28]. Encouraged by the wide sub-
strate scope of U-5C-4CR encountered, we decided to inves-
tigate the possible use of various aliphatic ketones as car-
bonyl inputs for the condensations with secondary amino
acids. Since U-5C-4CR of an enantiopure amino acid and an
unsymmetrical ketone proceeds with the formation of a new
stereogenic centre, we investigated the degree and the sense
of diastereoinduction.
Results and discussion
We chose L-proline, acetone, tert-butyl isocyanide and
methanol as model inputs for preliminary experiments
(Table 1). Propitiously, the Ugi product 1a formed with an
acceptable yield, after 1 day, at room temperature, without
use of any catalyst (Entry 1). When the reaction time was pro-
longed to 3 days (Entry 2), the yield improved, indicating that
U-5C-4CRs of secondary amino acids with ketones might
require longer completion times than analogous processes
for aldehydes. The reaction was inhibited by addition of 1 eq.
of an organic base (Entry 3), whereas a significant improve-
ment of chemical yields was achieved with catalytic amounts
of Lewis acids (Entries 4–5). TiCl4 proved superior to FeCl3
and was chosen for further studies. Neither increasing the
time of the catalysed reaction to 5 days (Entry 6) nor per-
forming the reaction at the lower (−20 ◦C) or higher (50 ◦C)
temperature (Entries 7–8) improved the reaction yield.
With the optimized reaction conditions in hand (Table 1,
Entry 5), we initiated investigations of the substrate scope
and limitations of the U-5C-4CR of secondary amino acids
and ketones (Fig. 1).
We initially examined symmetrical ketones as coupling
partners for L-proline, tert-butyl isocyanide and methanol
(Fig. 2). Chemical yields ranged from 0 to 61 % and were
largely dependent on the steric properties of the ketones
employed. The highest yield was achieved for the derivative
of the least bulky acetone, 1a; however, when the aliphatic
side chains of the ketone were expanded with methyl groups
in 1b, a markedly lower yield was observed. Given these
results, we were surprised to see no further drop of yield
when using more sterically hindered dibenzyl ketone for 1c.
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Entrya Additive Temperature Time (days) Conversion (%)b
1 – rt 1 30
2 – rt 3 39
3 TEAc rt 3 12
4 FeCld3 rt 3 53
5 TiCld4 rt 3 67
6 TiCld4 rt 5 65
7 TiCld4 −20 ◦C 3 50
8 TiCld4 50 ◦C 3 60
a Unless stated otherwise, the reactions were carried out in 0.1 M MeOH solutions on a 0.2 mmol scale. b Estimated by HPLC. c 1.0 eq. d 5 mol%
Fig. 1 Ketones, secondary amino acids and isocyanides used in the
U-5C-4CR
No desired product was formed when α-branched diisopropyl
ketone was used as a substrate.1
The results obtained for 1a–d indicated that the outcome
of U-5C-4CR is determined by the degree of steric hindrance
1 In cases where either no U-5C-4CR products were formed or low
yields were observed, the starting materials could be recovered from
the post-condensation mixtures. No side products were detected.
around the α-carbon of the ketone. This finding could be
explained by unfavourable steric interactions of the alkyl
groups of the carbonyl component with the carboxylate in the
zwitterionic imine intermediate (Fig. 3). These interactions
were markedly more pronounced for α branched ketones.
In agreement with this elucidation, less conformationally
strained cyclic ketones gave adducts 1e–h with chemical
yields comparable to those obtained for acetone.
Aware of the possible unfavourable steric interactions in
the U-5C-4CR intermediate, we next investigated the influ-
ence of the steric hindrance of the isocyanide component
on the outcome of the condensation (Fig. 2, adducts 1i–l).
A decrease in the steric hindrance of the isocyanide had an
enhancing effect only when bulky ketones were employed as
substrates. Thus, no significant enhancement was observed
when tert-butyl isocyanide was replaced by tosylmethyl
(product 1i) or n-butyl (product 1j) isocyanide as a coupling
partner for unbulky cyclopentanone. On the contrary, when
the more bulky and flexible dibenzyl ketone was reacted with
n-butyl isocyanide (product 1k), the chemical yield increased
more than twofold compared with the analogous reaction for
1c. Again, no adduct was formed when diisopropyl ketone
was used as a substrate.
Other secondary amino acids were coupled with symmet-
rical ketones producing adducts 1m–t, with chemical yields
ranging from 0 to 51 % (Fig. 4). Trans-hydroxy-L-proline
condensed with cyclopentanone, tert-butyl isocyanide and
methanol to form 1m with significantly lower yield than an
analogous reaction for L-proline. This was due to the poor
solubility of the amino acid in methanol. Higher yield was
obtained when the solvent was changed to DMF/MeOH 1:1
(v/v). The amino acids containing aromatic amino groups,
(S)-indolinecarboxylic acid and N-phenylglycine gave prod-
ucts 1n and 1o, respectively, with good yield. Surpris-
ingly, the efficiency of the U-5C-4CR of L-pipecolic acid
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Fig. 2 U-5C-4CR of L-proline,
various symmetrical ketones,
isocyanides and methanol.
Reactions were carried out in
0.2 M MeOH solutions on a
4.2–8.4 mmol scale. All yields
are isolated yields
Fig. 3 Possible unfavourable










with cyclopentanone and tert-butyl isocyanide (product 1q)
was significantly lower than that for homologous L-proline
(Fig. 2, product 1f). When the hindered isocyanide was
replaced with its linear isomer, a twofold increase in yield
of coupling adduct 1r was observed. Contrary to what had
been observed with the formation of L-proline derivatives 1c
and 1k (Fig. 2), the reactions of L-pipecolic acid with bulky
dibenzyl ketone and either tert-butyl or n-butyl isocyanide
failed to proceed. This significant loss of reactivity could
be ascribed to the greater steric bulk or increased confor-
mational flexibility of this amino acid when compared with
homologous L-proline.
Once the substrate scope and limitations of U-5C-4CR of
secondary amino acids and symmetrical ketones had been
determined, we turned our attention to analogous condensa-
tions of prochiral, unsymmetrical ketones (Fig. 5). Initially,
L-proline and tert-butyl isocyanide were used as coupling
partners for 2-butanone, 3-methyl-2-butanone and 1-phenyl-
2-propanone. As expected, the chemical yields of the cor-
responding adducts 1u, 1v and 1w were markedly higher
than those for the derivatives of similar symmetrical ketones
(Fig. 2, compounds 1b, 1d and 1c, respectively). Nonethe-
less, the same trend in reactivity was observed. The low-
est yield was obtained for the 3-methyl-2-butanone adduct
1v, incorporating branched isopropyl chain. The yields of
the condensation products of the remaining two ketones, 2-
butanone and 1-phenyl-2-propanone (compounds 1u and 1w,
respectively), were roughly equal. Similar to what had been
observed for symmetrical ketones, changing tert-butyl iso-
cyanide to a less bulky tosylmethyl or n-butyl isocyanide
greatly enhanced formation of derivatives of the hindered
3-methyl-2-butanone (Fig. 5, compounds 1x and 1v).
The degree of diastereoinduction obtained for adducts
1u–z depended largely on the structure of the isocyanide
input. The relatively high diastereoselectivity was observed
for derivatives of hindered tert-butyl isocyanide 1u and 1v.
Surprisingly, almost equal amounts of diastereoisomers were
formed for 1w. When the isocyanide was changed to a less
bulky tosylmethyl or n-butyl isocyanide, adducts 1x, 1y and
1z were formed with only modest or trace diastereoinduction.
We subsequently investigated the sense of diastereoin-
duction for products 1u, 1v and 1x. In accordance with the
Ugi’s pioneering report, the sense of diastereoinduction of
U-5C-4CR of amino acids and aldehydes is (S, S) [19],
which was also confirmed by us and others [20,28]. How-
ever, some reports have observed opposite diastereoselec-
tivity [22,24,26,27], indicating that the stereochemical out-
comes of U-5C-4CR may be highly sensitive to the nature of
coupling reagents and reaction conditions.
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Reactions were carried out in
0.2 M solutions on a 4.2–8.4
mmol scale. All yields are
isolated yields
Fig. 5 U-5C-4CR of L-proline,
various unsymmetrical ketones,
isocyanides and methanol.
Reactions were carried out in 0.2
M MeOH solutions on a 4.2–8.4
mmol scale. With the exception
of 1u, the diastereomeric
mixtures were resolved by
column chromatography. All
yields are isolated yields. aThe
diastereomeric ratios of
(2S, 1R)/(2S, 1S), estimated by
LC/MS of the crude reaction
mixtures. bThe diastereomeric
ratios of major/minor, estimated
by LC/MS of the crude reaction
mixtures
Since the rotation around the N-C1 bond of the products
1 was unrestricted, the direct NOE measurements could not
be considered diagnostic for determination of the relative
configurations. Therefore, 1u, 1v and 1x2 were converted
2 The differences in the 1H and 13C NMR spectra of the respective
diastereomers of 1 were not consistent and did not allow for easy
into the corresponding rigid, cyclic derivatives 3u, 3v and 3x
(Schemes 2, 3 and 4, respectively).
Footnote 2 countinued
differentiation. Therefore, the conversion to the corresponding cyclic
forms was necessary in all cases. Determination of absolute chemistry
of compounds 1w, 1y, 1z, for which the diastereoinduction was negli-
gible, was not performed.
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NaOH (1 eq), EtOH
rt, 5 min.
(74%)
(2S,1R)-2u, 10% (4S,8aS)-3u, 11%(4R,8aS)-3u, 44%
Scheme 2 Synthesis of cyclic derivatives (4R, 8aS)-3u and (4S, 8aS)-3u
BF3*2CH3COOH


































NaOH (1 eq), EtOH
rt, 5 min.
Scheme 3 Synthesis of cyclic derivatives (4R, 8aS)-3v and (4S, 8aS)-3v
Direct base-induced cyclocondensation of 1u and 1v to
their corresponding N-tert-butylated imides failed. There-
fore, N-detert-butylation/cyclocondensation sequence lead-
ing to N-unsubstituted cyclic derivatives was chosen as
an alternative pathway (Schemes 2 and 3, respectively).
The diastereomeric mixture of 1u was treated with BF3 ∗
2CH3COOH at 50 ◦C to afford a chromatographically sepa-
rable mixture of N-detert-butylated amidoester (2S, 1R)-2u3
(10 %) and cyclic imides (4R, 8aS)-3u (44 %), (4S, 8aS)-
3u (11 %). Subsequently, (2S, 1R)-2u was converted to
(4R, 8aS)-3u upon treatment with base. The stereochemis-
tries of (4R, 8aS)-3u and (4S, 8aS)-3u were determined by
the observation of characteristic correlations in their NOESY
spectra (Fig. 6). Another spectroscopic feature which was
useful for distinguishing between the respective diastereoiso-
mers of 3u was the characteristic difference in the chemical
shifts and shapes of multiplets of protons H-8a, H-6 and H′-6.
The above results indicated that the sense of diastereoinduc-
tion for the formation of 1u was (2S, 1R).
3 (2S, 1S)-1u could not be isolated from the post-reaction mixture,
most probably due to its full conversion to (4S, 8aS)-3u.
Unlike 1u, which produced the desired, separable cyclic
derivatives 3u directly upon treatment with BF3 ∗ 2CH3
COOH at 50 ◦C, the diastereomeric mixture of 1v gave
(2S, 1R)-2v (12 %), (2S, 1S)-2v (34 %) and a chromato-
graphically inseparable diastereomeric mixture of (4R, 8aS)-
3v and (4S, 8aS)-3v (dr=30/70, 1H NMR). However, the
resulting amidoesters (2S, 1R)-2v and (2S, 1S)-2v could
be chromatographically separated. They were subsequently
treated with 1 eq. of NaOH to afford (4R, 8aS)-3v and
(4S, 8aS)-3v, with chemical yields of 86 and 82 %, respec-
tively. Relative configurations of the diastereomers of 3v
were assigned by comparing their 1H NMR spectra to those
of (4R, 8aS)-3u and (4S, 8aS)-3u. Surprisingly, the sense
of diastereoinduction for the formation of 1v was reversed
compared to 1u.
In contrast to 1u and 1v, for which the base-induced
cyclization failed, the respective diastereomers of 1x could be
converted to the corresponding cyclic imides (4R, 8aS)-3x
and (4S, 8aS)-3x directly upon treatment with 1 eq. NaOH
in EtOH. The reaction was accompanied by the tosyl-ethoxyl
exchange, which was in agreement with earlier observations
made by van Leusen et al during their investigationsof tosyl-
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NaOH (1 eq), EtOH
rt, 5 min.
Scheme 4 Synthesis of cyclic derivatives (4R, 8aS)-3x and (4S, 8aS)-
3x
Fig. 6 Selected NOESY correlations in (4R, 8aS)-3u and (4S, 8aS)-
3u
methyl isocyanide derivatives [29]. The configurations of
(4R, 8aS)-3x and (4S, 8aS)-3x were assigned by analysis
of characteristic patterns of their 1H NMR spectra. In view
of the above, (2S, 1R)-1x was the major isomer in the post
reaction mixture, contrary to what had been assigned for 1v.
The observed degree and sense of diastereoinduction
observed for the formation of compounds 1u, 1v, 1w and
1x was not always consistent and could not be easily ratio-
nalized. In general, the stereochemical outcomes depended
on the structure of both the isocyanide and the ketone inputs.
Furthermore, the interactions of these two components with
the rigid L-proline framework cannot be neglected. This
was evaluated by the results of an additional experiment
in which no diastereoselectivity was observed in the U-5C-
4CR of bulky tert-butyl isocyanide, 2-butanone and con-
formationally flexible primary amino acid, L-phenylalanine
(Scheme 5). Surprisingly, its secondary analogue, N-methyl-
L-phenylalanine, failed to react under the same conditions.
Conclusions
Experimental results show that various symmetrical and
unsymmetrical ketones can be successfully used as coupling
partners for secondary amino acids in the course of the U-5-
C-4CR. Outcomes of these condensations seemed to depend
on the hindrance and the components employed. Even very
subtle differences in coupling reagents caused significant
changes of both yields and stereochemical outcomes. In most
cases, the chemical yields were satisfactory in view of pos-
sible steric interactions in the U-5C-4CR zwitterionic inter-
mediate. When unsymmetrical ketones were used as prochi-
ral carbonyl inputs for coupling with bulky tert-butyl iso-
cyanide, high diastereoselectivities were usually observed.
Although the sense of diastereoinduction was not consis-
tent and could not be easily rationalized, we believe that
some more general conclusions could be drawn from ade-
quately designed experiments combined with computational
methods. Therefore, in our opinion the presented variation
of components for U-5C-4CR is not only capable of expand-
ing the molecular diversity generated by the reaction, but can
also serve as a potential basis for investigations of its mecha-




The NMR spectra were obtained on a Varian VNMRS 300
MHz or Varian Inova 500 MHz spectrometer at room temper-
ature. Chemical shifts (δ) were expressed in parts per million
(ppm) relative to tetramethylsilane (TMS) or residual sol-
vent peaks used as the internal references. The following
abbreviations were used to describe the signal patterns: s
Scheme 5 Synthesis of
L-phenylalanine derivatives 4a
and 4b. The diastereomeric
ratios of major/minor were
estimated by LC/MS analysis of
the crude reaction mixture
O 5 mol-%TiCl4
MeOH










R = -H: 4a, 43%, dr=50:50
-Me: 4b, no reaction
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(singlet), d (doublet), t (triplet), q (quartet), m (multiplet),
p (pseudo-) and b (broad-). Coupling constants (J ) were
in hertz (Hz). The FT-IR spectra (thin film on KBr pellets)
were recorded on a Shimadzu FT-IR8300 instrument. High-
resolution mass spectra (HRMS) were obtained using a LCT-
TOF (Micromass) spectrometer with electrospray ionization
(ESI). Optical rotations were measured with a Perkin-Elmer
241 polarimeter using a sodium lamp (589 nm). Melting
points were determined on an Electrothermal 9100 appa-
ratus in open capillary tubes and are uncorrected. LC/MS
analyses were performed using a Shimadzu Nexera UHPLC
system with LCMS-2020 single quadrupole spectrometer
equipped with an ESI ion source. Supelcosil LC-18-DB col-
umn (length: 25 mm, internal diameter: 4.6 mm, particle size:
5 μm) was used. The analyte concentration: approximately
50 ng/mL, injection: 5 μL, flow rate 0.4 mL/min, temper-
ature: 60 ◦C, mobile phase: acetonitrile/water 60:40 (v/v).
Thin-layer chromatography (TLC) was run on Merck silica
gel (60-F254) plates. The spots were visualized by ultraviolet
light (254 nm) or iodine vapors. Flash column chromatog-
raphy (FC) was carried out on silica gel 60 (particle size:
0.040–0.063 mm).
General procedure for the U-5C-4CR condensation
To a stirred solution of an α-amino acid (1.2 eq.) and ketone
(1.0 eq.) in MeOH (5 mL per 1 mmol of ketone) titanium
(IV) chloride (5 mol%) was added, followed by isocyanide
(1.0 eq.). The mixture was stirred at room temperature for 3
days and the volatiles were removed under reduced pressure.
The resulting crude products were purified by FC.
Methyl (2S)-1-(1-(tert-butylcarbamoyl)-1-methyl-1-ethyl)-
pyrrolidine-2-carboxylate 1a
From L-proline (1.16 g, 10.08 mmol), acetone (0.62 mL, 8.40
mmol) and tert-butyl isocyanide (0.95 mL, 8.40 mmol); FC
(gradient: PE/AcOEt 9:1 to 3:1): yield 1.39 g (61 %). White
wax, M.p. 45–46 ◦C; TLC (PE/AcOEt 5:1): Rf = 0.29;
[α]D = −34.7 (c1, CHCl3); IR (KBr): 1200, 1454, 1516,
1678, 1744, 2970, 3348; 1H NMR (CDCl3, 500 MHz): δ
1.16 (s, 3H, CH3), 1.21 (s, 3H, CH3), 1.32 (s, 9H, C(CH3)3),
1.74–1.85 (m, 2H, H-4, H′-4), 1.87 (m, 1H, H-3), 1.99 (m,
1H, H′-3), 2.69 (m, 1H, H-5), 2.97 (m, 1H, H′-5), 3.61 (dd,
3 J1 = 9.5,3 J2 = 2.5, 1H, H-2), 3.71 (s, 3H, OCH3),
7.44 (bs, 1H, CONH); 13C NMR (CDCl3, 125 MHz): δ
21.7 (CH3), 22.3 (CH3), 24.5 (C-4), 29.0 (C(CH3)3), 32.3
(C-3), 48.6 (C-5), 50.6 (C(CH3)3), 52.4 (OCH3), 60.1 (C-
2), 63.2 (C-1), 176.4 (CONH), 177.7 (COOCH3); HRMS




From L-proline (1.16 g, 10.08 mmol), 3-pentanone (0.89
mL, 8.40 mmol) and tert-butyl isocyanide (0.95 mL, 8.40
mmol); FC (gradient: PE/AcOEt 10:1 to 4:1): yield 0.40 g
(16 %). White wax; M.p. 47–48 ◦C; TLC (PE/AcOEt 5:1):
Rf = 0.42; [α]D = −2.5 (c 0.950, CHCl3); IR (KBr):
667, 769, 1198, 1455, 1520, 1674, 1735, 2880, 2966, 3316;
1H NMR (CDCl3, 300 MHz): δ 0.74 (t, 3 J = 7.5, 3H,
CH2CH3), δ 0.83 (t, 3 J = 7.5, 3H, CH2CH′3), 1.35 (s,
9H, C(CH3)3), 1.47–1.94 (m, 8H, 2xCH2, H-3, H′-3, H-
4, H′-4), 2.10 (m, 1H, H-5), 2.74 (m, 1H, H′-5), 3.73 (s,
3H, OCH3), 4.09 (dd, 3 J1 = 9.0,3 J2 = 1.0, 1H, H-2), 8.14
(bs, 1H, CONH); 13C NMR (CDCl3, 75 MHz): δ 7.3, 9.3
(2xCH3), 20.9, 24.3, 26.9, 28.9 (C(CH3)3), 31.8 (C-3), 47.4
(C-5), 50.2 (C(CH3)3), 52.3 (OCH3), 59.2 (C-2), 66.7 (C-
1), 175.7 (CONH), 179.1 (COOCH3); HRMS (ESI+) calcd
for C16H30N2O3Na: 321.2154 (M+Na)+ found 321.2151.
Methyl (2S)-1-(1-(tert-butylcarbamoyl)-1-benzyl-3-phenyl-
1-ethyl)-pyrrolidine-2-carboxylate 1c
From L-proline (1.16 g, 10.08 mmol), diphenyl-2-propanone
(1.77 g, 8.40 mmol) and tert-butyl isocyanide (0.95 mL, 8.40
mmol); FC (gradient: PE/AcOEt 12:1 to 8:1): yield 0.60 g
(17 %). Yellow oil; TLC (PE/AcOEt 5:1): Rf = 0.48; [α]D =
−46.2 (c 0.792, CHCl3); IR (KBr): 668, 669, 745, 1212,
1455, 1514, 1679, 1734, 2872, 2963, 3313; 1H NMR (CDCl3,
300 MHz): δ 1.30 (s, 9H, C(CH3)3), 1.70–1.86 (m, 4H, H-
3, H′-3, H-4, H′-4), 2.87 (d, 2 J = 13.5, 1H, CH2), 3.07 (m,
2H, H-5, CH2), 3.09–3.22 (m, 3H, H′-5, 2xCH ′2), 3.64 (s, 3H,
OCH3), 3.67 (m, 1H, H-2), 7.13–7.38 (m, 10H, H-Ar), 7.66
(bs, 1H, CONH); 13C NMR (CDCl3, 75 MHz): δ 23.8 (C-4),
28.5 (C(CH3)3), 31.7 (C-3), 37.1 (CH2), 40.6 (CH′2), 47.9
(C-5), 50.5 (C(CH3)3), 52.0 (OCH3), 59.9 (C-2), 68.9 (C-1),
126.5, 126.7, 127.9, 128.0, 130.79, 130.83, 136.9, 138.2 (C-
Ar), 173.5 (CONH), 178.7 (COOCH3); HRMS (ESI+) calcd
for C26H34N2O3Na: 445.2467 (M+Na)+ found 445.2451.
Methyl (2S)-1-(1-(tert-butylcarbamoyl)-cyclohexyl)-
pyrrolidine-2-carboxylate 1e
From L-proline (1.16 g, 10.08 mmol), cyclohexanone (0.87
mL, 8.40 mmol) and tert-butyl isocyanide (0.95 mL, 8.40
mmol); FC (gradient: PE/AcOEt 10:1 to 3:1): yield 1.23 g
(47 %). Pale-yellow oil; TLC (PE/AcOEt 5:1): Rf = 0.49;
[α]D = −15.0 (c 0.613, CHCl3); IR (KBr): 668, 766,
1199, 1455, 1510, 1679, 1738, 2863, 2933, 3331; 1H NMR
(CDCl3, 300 MHz): δ 1.34 (s, 9H, C(CH3)3), 1.44–1.68
(m, 6H), 1.68–1.91 (m, 6H), 1.91–2.06 (m, 2H), 2.81 (m,
2 J =3 J1 = 8.5,3 J2 = 6.0, 1H, H-5), 2.91 (m, 1H, H′-5),
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3.70 (s, 3H, OCH3), 3.78 (dd, 3 J1 = 9.0,3 J2 = 2.5, 1H,
H-2), 7.13 (bs, 1H, CONH); 13C NMR (CDCl3, 75 MHz): δ
23.4, 23.6, 25.1, 26.3, 29.1 (C(CH3)3), 30.3, 32.3, 33.6, 47.7
(C-5), 50.6 (C(CH3)3), 52.4 (OCH3), 59.1 (C-2), 64.8 (C-
1), 175.8 (CONH), 178.2 (COOCH3); HRMS (ESI+) calcd
for C17H30N2O3Na: 333.2154 (M+Na)+ found 333.2148.
Methyl (2S)-1-(1-(tert-butylcarbamoyl)-cyclopentyl)-
pyrrolidine-2-carboxylate 1f
From L-proline (1.16 g, 10.08 mmol), cyclopentanone (0.74
mL, 8.40 mmol) and tert-butyl isocyanide (0.95 mL, 8.40
mmol); FC (gradient: PE/AcOEt 10:1 to 3:1): yield 1.50
g (60 %). Colorless oil; TLC (PE/AcOEt 5:1): Rf = 0.41;
[α]D = −12.0 (c 0.325, CHCl3); IR (KBr): 768, 1199, 1456,
1509, 1681, 1737, 2875, 2966, 3368; 1H NMR (CDCl3, 300
MHz): δ 1.34 (s, 9H, C(CH3)3), 1.45–2.22 (m, 12H), 2.66
(m, 2 J =3 J1 = 8.5,3 J2 = 7.0, 1H, H-5), 3.03 (m, 1H,
H′-5), 3.61 (dd, 3 J1 =9.5,3 J2 = 2.5, 1H, H-2), 3.73 (s, 3H,
OCH3), 7.58 (bs, 1H, CONH); 13C NMR (CDCl3, 75 MHz):
δ 24.8, 25.5, 25.7, 28.8 (C(CH3)3), 32.0, 32.4, 34.9, 49.3 (C-
5), 50.2 (C(CH3)3), 52.2 (OCH3), 60.5 (C-2), 73.8 (C-1),
176.3 (CONH), 177.5 (COOCH3); HRMS (ESI+) calcd for
C16H28N2O3Na: 319.1998 (M+Na)+ found 319.1995.
Methyl (2S)-1-(1-(tert-butylcarbamoyl)-cyclobutyl)-
pyrrolidine-2-carboxylate 1g
From L-proline (1.16 g, 10.08 mmol), cyclobutanone (0.63
mL, 8.40 mmol) and tert-butyl isocyanide (0.95 mL, 8.40
mmol); FC (gradient: PE/AcOEt 10:1 to 3:1): yield 1.12
g (47 %). Yellow oil; TLC (PE/AcOEt 5:1): Rf = 0.33;
[α]D = +4.4 (c 0.607, CHCl3); IR (KBr): 765, 1202, 1457,
1514, 1680, 1739, 2871, 2959, 3335; 1H NMR (CDCl3, 300
MHz): δ 1.35 (s, 9H, C(CH3)3), 1.66 (m, 1H), 1.74–2.24 (m,
8H), 2.47 (m, 1H), 2.76 (m, 2 J =3 J1 = 8.5,3 J2 = 7.0,
1H, H-5), 2.90 (m, 1H, H′-5), 3.71 (m, 4H, H-2, OCH3),
7.42 (bs, 1H, CONH); 13C NMR (CDCl3, 75 MHz): δ
14.4, 24.9, 25.8, 28.9 (C(CH3)3), 30.2, 31.5, 48.3 (C-5),
50.2 (C(CH3)3), 52.2 (OCH3), 60.2 (C-2), 66.6 (C-1),
175.2 (CONH), 176.8 (COOCH3); HRMS (ESI+) calcd for
C19H28N2O3Na: 305.1847 (M+Na)+ found 305.1841.
Methyl (2S)-1-(4-(tert-butylcarbamoyl)-4-
tetrahydropyranyl)-pyrrolidine-2-carboxylate 1h
From L-proline (1.16 g, 10.08 mmol), 4-oxotetrahydropyran
(0.78 mL, 8.40 mmol) and tert-butyl isocyanide (0.95 mL,
8.40 mmol); FC (gradient: PE/AcOEt 10:1 to 3:1): yield 0.94
g (36 %). White powder; M.p. 97–99 ◦C; TLC (PE/AcOEt
5:1): Rf = 0.11; [α]D = −15.3 (c 0.945, CHCl3); IR (KBr):
668, 760, 1202, 1455, 1512, 1677, 1739, 2869, 2959, 3360;
1H NMR (CDCl3, 300 MHz): δ 1.34 (s, 9H, C(CH3)3),
1.56 (m,2 J = 13.5, 3 J1 = 11.5,3 J2 = 6.0, 1H), 1.70
(m, 2H), 1.78 (m, 2H), 1.87 (m, 1H), 1.92–2.07 (m, 2H),
2.79 (m, 2 J =3 J1 = 8.5,3 J2 = 7.5, 1H, H-5), 2.91
(m, 1H, H′-5), 3.64 (m, 1H), 3.70 (s, 3H, OCH3), 3.72–
3.90 (m, 3H), 3.78 (td, 2 J =3 J1 = 11.5,3 J2 = 2.5,
1H), 7.23 (bs, 1H, CONH); 13C NMR (CDCl3, 75 MHz):
δ 25.0, 29.1 (C(CH3)3), 30.6, 32.1, 33.6, 47.4 (C-5), 50.7
(C(CH3)3), 52.5 (OCH3), 58.8 (C-2), 62.3 (C-1), 65.1, 66.1,
175.2 (CONH), 177.8 (COOCH3); HRMS (ESI+) calcd for
C16H28N2O4Na: 355.1947 (M+Na)+ found 355.1952.
Methyl (2S)-1-(1-(tosylmethylcarbamoyl)-cyclopentyl)-
pyrrolidine-2-carboxylate 1i
From L-proline (1.16 g, 10.08 mmol), cyclopentanone (0.74
mL, 8.40 mmol) and tosylmethyl isocyanide (1.64 g, 8.40
mmol); FC (gradient: PE/AcOEt 5:1 to 1:1): yield 1.90
g (55 %). Pale-yellow oil; TLC (PE/AcOEt 3:1): Rf =0.13;
[α]D = +4.1 (c 1.310, CHCl3); IR (KBr): 566, 758,
1142, 1321, 1455, 1495, 1692, 1733, 2873, 2953, 3339;
1H NMR (CDCl3, 300 MHz): δ 1.36–1.69 (m, 6H), 1.70–
1.97 (m, 4H), 2.04 (m, 2H), 2.43 (s, 3H, CH3), 2.57 (m,
2 J =3 J1 = 9.0,3 J2 = 6.5, 1H, H-5), 2.90 (m, 1H, H′-
5), 3.61 (dd, 3 J1 = 9.5,3 J2 = 3.0, 1H, H-2), 3.76 (s,
3H, OCH3), 4.71 (d, 2 J =3 J = 7.0, 2H, CH2), 7.32 (d,
3 J = 8.0, 2H, H-Ar), 7.80 (d, 3 J = 8.0, 2H, H-Ar), 8.63
(pt, 3 J = 7.0, 1H, CONH); 13C NMR (CDCl3, 75 MHz): δ
21.9, 24.7, 24.9, 31.2, 31.7, 36.2, 49.3 (C-5), 52.5 (OCH3),
59.9, 60.9, 72.9 (C-1), 129.0, 129.9, 134.8, 145.2 (4xC-Ar),
177.0 (CONH), 177.4 (COOCH3); HRMS (ESI+) calcd for
C20H28N2O5SNa: 431.1617 (M+Na)+ found 431.1601.
Methyl (2S)-1-(1-(n-butylcarbamoyl)-cyclopentyl)-
pyrrolidine-2-carboxylate 1j
From L-proline (0.58 g, 5.04 mmol), cyclopentanone (0.37
mL, 4.20 mmol) and n-butyl isocyanide (0.44 mL, 4.20
mmol); FC (gradient: PE/AcOEt 7:1 to 3:1): yield 0.83 g
(67 %). Pale-yellow oil; TLC (PE/AcOEt 5:1): Rf = 0.26;
[α]D = +3.6 (c 0.875, CHCl3); IR (KBr): 668, 760,
1199, 1457, 1518, 1676, 1737, 2871, 2956, 3339; 1H NMR
(CDCl3, 300 MHz): δ 0.93 (t, 3 J = 7.0, 3H, CH3), 1.36
(m, 2H), 1.43–1.68 (m, 6H), 1.68–2.13 (m, 7H), 2.21 (m,
1H), 2.65 (m, 2 J =3 J1 = 9.0,3 J2 = 7.0, 1H, H-5),
2.99 (m, 2H, H′-5), 3.16 (m, 1H), 3.28 (m, 1H), 3.62 (dd,
3 J1 = 9.5,3 J2 = 2.5, 1H, H-2), 3.71 (s, 3H, OCH3), 7.69
(pt, 3 J = 5.5, 1H, CONH); 13C NMR (CDCl3, 75 MHz): δ
14.3, 20.6, 25.1, 25.6, 25.8, 32.2, 32.2, 32.4, 35.9, 39.4, 49.6
(C-5), 52.5 (OCH3), 60.5, (C-2), 73.5 (C-1), 177.2 (CONH),
177.9 (COOCH3); HRMS (ESI+) calcd for C16H28N2O3Na:
319.1998 (M+Na)+ found 319.2012.
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Methyl (2S)-1-(1-(n-butylcarbamoyl)-1-benzyl-3-phenyl-1-
ethyl)-pyrrolidine-2-carboxylate 1k
From L-proline (0.58 g, 5.04 mmol), diphenyl-2-propanone
(0.88 g, 4.20 mmol) and n-butyl isocyanide (0.44 mL, 4.20
mmol); FC (gradient: PE/AcOEt 10:1 to 4:1): yield 0.69 g
(39 %). Pale-yellow oil; TLC (PE/AcOEt 5:1): Rf = 0.27;
[α]D = −50.5 (c 1.340, CHCl3); IR (KBr): 669, 700, 750,
1169, 1210, 1454, 1522, 1672, 1730, 2870, 2954, 3325;
1H NMR (CDCl3, 500 MHz): δ 0.93 (t, 3 J = 7.5, 3H,
CH2CH2CH2CH3), 1.35 (m, 2H, CH2CH2CH2CH3), 1.46
(m 2H, CH2CH2CH2CH3), 1.72–1.87 (m, 4H, H-3, H′-3, H-
4, H′-4), 2.86 (d, 2 J = 13.5, 1H, CH2), 3.07–3.21 (m, 6H,
H-5, H′-5, CH2, 2xCH ′2,CH2CH2CH2CH3), 3.27 (m, 1H,
CH2CH2CH2CH3), 3.61 (s, 3H, OCH3), 3.71 (m, 1H, H-2),
7.18–7.37 (m, 10H, H-Ar), 7.86 (bpt, 3 J = 5.5, 1H, CONH);
13C NMR (CDCl3, 125 MHz): δ 14.1 (CH2CH2CH2CH3),
20.6 (CH2CH2CH2CH3), 24.1 (C-4), 31.7 (C-3), 31.9
(CH2CH2CH2CH3), 37.8 (CH2CH2CH2CH3), 39.6 (CH2),
40.9 (CH′2), 48.1 (C-5), 52.3 (OCH3), 60.2 (C-2), 69.3 (C-
1), 126.8, 127.0, 128.28, 128.32, 130.95, 130.99, 137.1,
138.2 (C-Ar), 174.6 (CONH), 179.1 (COOCH3); HRMS




From trans-4-hydroxy-L-proline (1.32 g, 10.08 mmol),
cyclopentanone (0.74 mL, 8.40 mmol) and tert-butyl iso-
cyanide (0.95 mL, 8.40 mmol); FC (gradient: PE/AcOEt 5:1
to 1:2): yield 0.18 g (7 %). Pale-yellow wax; M.p. 56–63 ◦C;
TLC (PE/AcOEt 3:1): Rf = 0.09; [α]D = +0.5 (c 0.840,
CHCl3); IR (KBr): 768, 1202, 1455, 1507, 1652, 1734, 2873,
2960, 3311; 1H NMR (CDCl3, 300 MHz): δ 1.34 (s, 9H,
C(CH3)3), 1.54–1.90 (m, 7H), 2.00 (m, 1H), 2.09–2.24 (m,
2H), 2.58 (bs, 1H OH), 2.67 (4d, 2 J = 10.0, 3 J1 = 4.5,
3 J2 = 1.0, 1H, H-5), 3.26 (dd, 2 J =3 J1 = 10.0, 3 J2 = 5.0,
1H, H′-5), 3.73 (s, 3H, OCH3), 3.86 (dd, 3 J1 = 8.0, 3 J2 =
6.5, 1H, H-2), 4.39 (m, 1H, H-4), 7.36 (bs, 1H, CONH); 13C
NMR (CDCl3, 75 MHz): δ 25.2, 25.5, 29.1 (C(CH3)3), 29.4,
36.6, 40.5, 50.7, 52.6, 57.7, 59.9, 70.6, 74.1, 176.5 (CONH),
177.7 (COOCH3); HRMS (ESI+) calcd for C16H28N2O4Na:
335.1947 (M+Na)+ found 335.1948.
Methyl (2S)-1-(1-(tert-butylcarbamoyl)-cyclopentyl)-
indoline-2-carboxylate 1n
From (S)-(-)-indoline-2-carboxylic acid (1.64 g, 10.08
mmol), cyclopentanone (0.74 mL, 8.40 mmol) and tert-butyl
isocyanide (0.95 mL, 8.40 mmol); FC (gradient: PE/AcOEt
10:1 to 7:1): yield 1.47 g (51 %). Pale-yellow wax; M.p. 93–
95 ◦C; TLC (PE/AcOEt 5:1): Rf = 0.41; [α]D = +13.7
(c 0.913, CHCl3); IR (KBr): 745, 1202, 1457, 1515, 1539,
1680, 1738, 2874, 2960, 3334; 1H NMR (CDCl3, 300 MHz):
δ 1.34 (s, 9H, C(CH3)3), 1.50–166 (m, 3H), 1.67–1.98 (m,
4H), 2.68 (m, 1H), 3.04 (dd, 2 J = 16.5, 3 J = 6.0, 1H, H-3),
3.57 (dd, 2 J = 16.5, 3 J = 12.0, 1H, H′-3), 3.82 (s, 3H,
OCH3), 4.48 (dd, 3 J1 = 12.0, 3 J2 = 6.0, 1H, H-2), 6.41
(d, 3 J = 8.0, 1H, H-Ar), 6.68 (dt, 3 J=7.5, 4 J=0.5, 1H, H-
Ar), 7.00 (m, 2H, H-Ar), 8.16 (bs, 1H, CONH); 13C NMR
(CDCl3, 75 MHz): δ 25.3, 25.5, 28.9 (C(CH3)3), 32.1, 34.7,
38.0, 50.9, 53.1, 61.4, 72.4, 111.0, 118.9, 124.3, 127.5, 127.9,
148.8 (C-Ar), 174.9 (CONH), 176.8 (COOCH3); HRMS




From N -phenylglycine (1.52 g, 10.08 mmol), cyclopen-
tanone (0.74 mL, 8.40 mmol) and tert-butyl isocyanide (0.95
mL, 8.40 mmol); FC (gradient: PE/AcOEt 10:1 to 6:1): yield
0.92 g (33 %). White wax; M.p. 88–90 ◦C; TLC (PE/AcOEt
5:1): Rf = 0.40; IR (KBr): 693, 751, 1215, 1456, 1506, 1671,
1740, 2874, 2960, 3336; 1H NMR (CDCl3, 300 MHz): δ 1.18
(s, 9H, C(CH3)3), 1.52–1.72 (m, 2H), 1.72–1.96 (m, 4H),
2.45 (m, 2H), 3.83 (s, 3H, OCH3), 4.12 (s, 2H, CH2), 6.63
(m, 2H, H-Ar), 6.78 (m, 1H, H-Ar), 7.18 (m, 2H, H-Ar), 7.86
(bs, 1H, CONH); 13C NMR (CDCl3, 75 MHz): δ 25.8, 28.7
(C(CH3)3), 37.1, 49.4, 50.9, 53.0, 74.5, 115.5, 119.0, 129.3,
146.7 (C-Ar), 174.7 (CONH), 175.3 (COOCH3); HRMS




From N -benzylglycine (generated from N -benzylglycine
hydrochloride (1.69 g, 10.08 mmol) and triethylamine (1.40
mL, 10.08 mmol)), cyclopentanone (0.74 mL, 8.40 mmol)
and tert-butyl isocyanide (0.95 mL, 8.40 mmol); FC (gradi-
ent: PE/AcOEt 10:1 to 6:1): yield 0.58 g (20 %). White wax;
M.p. 36–37 ◦C; TLC (PE/AcOEt 5:1): Rf = 0.45; IR (KBr):
668, 745, 1201, 1455, 1510, 1677, 1744, 2872, 2959, 3347;
1H NMR (CDCl3, 300 MHz): δ 1.36 (s, 9H, C(CH3)3), 1.57–
1.82 (m, 6H), 2.06 (m, 2H), 3.20 (s, 2H), 3.50 (s, 3H, OCH3),
3.65 (s, 2H), 7.21-7.39 (m, 5H, H-Ar), 7.83 (bs, 1H, CONH);
13C NMR (CDCl3, 75 MHz): δ 25.9, 29.1 (C(CH3)3), 33.0,
50.6, 52.1, 56.8, 76.8, 127.7, 128.8, 129.0, 139.2 (C-Ar),
173.6 (CONH), 176.8 (COOCH3); HRMS (ESI+) calcd for
C20H30N2O3Na: 369.2154 (M+Na)+ found 369.2141.
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Methyl (2S)-1-(1-(tert-butylcarbamoyl)-cyclopentyl)-
piperidine-2-carboxylate 1q
From L-pipecolic acid (1.30 g, 10.08 mmol), cyclopentanone
(0.74 mL, 8.40 mmol) and tert-butyl isocyanide (0.95 mL,
8.40 mmol); FC (gradient: PE/AcOEt 10:1 to 7:1): yield 0.31
g (12 %). Pale-yellow oil; TLC (PE/AcOEt 5:1): Rf = 0.51;
[α]D = +10.1 (c 0.933, CHCl3); IR (KBr): 668, 772, 1159,
1456, 1508, 1518, 1539, 1680, 1736, 2869, 2954, 3316;
1H NMR (CDCl3, 300 MHz): δ 1.34 (s, 9H, C(CH3)3),
1.37–1.92 (m, 12H), 1.98 (m, 2H), 2.49 (dt, 2 J = 12.5,
3 J1 =3 J2 =4.0, 1H, H-6), 3.14 (td, 2 J = 12.5, 3 J1 =3
J2 = 3.5, 1H, H′-6), 3.69 (s, 3H, OCH3), 3.78 (m, 1H,
H-2), 7.54 (bs, 1H, CONH); 13C NMR (CDCl3, 75 MHz):
δ 21.0, 25.1, 25.3, 26.5, 29.1 (C(CH3)3), 30.0, 32.2, 34.2,
44.5, 50.4 (C(CH3)3), 51.9 (OCH3), 56.3 (C-2), 76.8 (C-1),
175.9 (CONH), 177.3 (COOCH3); HRMS (ESI+) calcd for
C17H30N2O3Na: 333.2154 (M+Na)+ found 333.2165.
Methyl (2S)-1-(1-(n-butylcarbamoyl)-cyclopentyl)-
piperidine-2-carboxylate 1r
From L-pipecolic acid (0.65 g, 5.04 mmol), cyclopentanone
(0.37 mL, 4.20 mmol) and n-butyl isocyanide (0.44 mL, 4.20
mmol); FC (gradient: PE/AcOEt 10:1 to 3:1): yield 0.33 g
(25 %). Pale-yellow oil; TLC (PE/AcOEt 5:1): Rf = 0.21;
[α]D = −2.0 (c 0.700, CHCl3); IR (KBr): 758, 1157, 1447,
1506, 1655, 1736, 2866, 2934, 3368; 1H NMR (CDCl3,
500 MHz): δ 0.93 (t, 3H, 3 J = 7.5, CH2CH2CH2CH3),
1.31–1.53 (m, 6H), 1.54–1.66 (m, 3H), 1.67–1.88 (m, 6H),
1.90–2.02 (m, 3H), 2.51 (dt, 2 J = 12.5, 3 J1 =3 J2 =
4.0, 1H, H-6), 3.12 (td, 2 J = 12.5, 3 J1 =3 J2 = 2.5,
1H, H′-6), 3.23 (m, 2H, CH2CH2CH2CH3), 3.70 (s, 3H,
OCH3), 3.79 (m, 1H, H-2), 7.69 (bpt,3 J =5.5, 1H, CONH);
13C NMR (CDCl3, 125 MHz): δ 14.1 (CH2CH2CH2CH3),
20.5 (CH2CH2CH2CH3), 21.0, 24.7, 24.9, 26.3, 29.7, 32.2,
32.7 (CH2CH2CH2CH3), 34.2, 39.3 (CH2CH2CH2CH3),
44.5, 51.8 (OCH3), 56.3 (C-2), 76.3 (C-1), 176.0 (CONH),
177.6 (COOCH3); HRMS (ESI+) calcd for C17H30N2O3Na:
333.2154 (M+Na)+ found 333.2167.
Methyl (2S, 1R)- and (2S, 1S)-1-(1-(tert-butylcarbamoyl)-
1-methyl-1-propyl)-pyrrolidine-2-carboxylate (2S, 1R)-1u
and (2S, 1S)-1u
From L-proline (1.16 g, 10.08 mmol), 2-butanone (0.75
mL, 8.40 mmol) and tert-butyl isocyanide (0.95 mL, 8.40
mmol); FC (gradient: PE/AcOEt 9:1 to 3:1): yield 0.98 g
(41 %) of chromatographically inseparable diastereomeric
mixture (dr = 86:14, LC/MS). A sample of diastereomer-
ically pure (2S, 1R)-1u (major isomer) was obtained by
recrystallization from PE. (2S, 1R)-1u: White wax, M.p.
53–54 ◦C; TLC (PE/AcOEt 5:1): Rf = 0.35; [α]D =
−19.0 (c 1, CHCl3); IR (KBr): 1200, 1454, 1508, 1678,
1744, 2962, 3360; 1H NMR (CDCl3, 500 MHz): δ 0.85
(t, 3 J = 7.5, 3H, CH2CH3), 1.12 (s, 3H, CH3), 1.30 (s,
9H, C(CH3)3), 1.66–2.02 (m, 6H, H-3, H′-3, H-4, H′-4,
CH2), 2.70 (m, 1H, H-5), 3.00 (m, 1H, H′-5), 3.72 (m,
4H, H-2, OCH3), 7.27 (bs, 1H, CONH); 13C NMR (from
diastereomeric mixture, CDCl3, 125 MHz): δ 8.5 (CH3),
15.8 (CH′3), 24.4 (C-4), 28.5 (C(CH3)3), 30.6 (CH2),
31.5 (C-3), 47.2 (C-5), 50.2 (C(CH3)3), 51.9 (OCH3),
60.7 (C-2), 65.7 (C-1), 174.9 (CONH), 177.4 (COOCH3);
LC/MS: 285 [M+H]+, retention time: 14.4 min; HRMS
(ESI+) calcd for C15H18N2O3Na: 307.1998 (M+Na)+ for
307.1969. (2S, 1S)-1u: 1H NMR (from diastereomeric mix-
ture, CDCl3, 500 MHz): δ 0.82 (t, 3 J = 7.5, 3H, CH2CH3),
1.08 (s, 3H, CH3), 1.35 (s, 9H, C(CH3)3), 1.66–1.90 (m,
5H, H-3, H-4, H′-4, CH2), 2.07 (m, 1H, H′-3), 2.70 (m, 1H,
H-5), 2.89 (m, 1H, H′-5), 3.66 (dd, 3 J1 = 10.0,3 J2 = 4.0,
1H, H-2), 3.72 (s, 3H, OCH3), 7.36 (bs, 1H, CONH); 13C
NMR (from diastereomeric mixture, CDCl3, 125 MHz): δ
9.2 (CH3), 13.8 (CH′3), 24.8 (C-4), 28.7 (C(CH3)3), 32.1 (C-
3), 31.5 (CH2), 48.7 (C-5), 50.1 (C(CH3)3), 51.9 (OCH3),
58.5 (C-2), 65.9 (C-1), 174.3 (CONH), 177.6 (COOCH3);
LC/MS: 285 [M+H]+, retention time: 13.6 min.
Methyl (2S, 1R)- and (2S, 1S)-1-(1-(tert-butylcarbamoyl)-
1,2-dimethyl-1-propyl)-pyrrolidine-2-carboxylate
(2S, 1R)-1v and (2S, 1S)-1v
From L-proline (1.16 g, 10.08 mmol), 3-methyl-2-butanone
(0.90 mL, 8.40 mmol) and tert-butyl isocyanide (0.95 mL,
8.40 mmol); FC (gradient: PE/AcOEt 10:1 to 5:1): yield
0.20 g (8 %): 0.03 g (1 %) of (2S, 1R)-1v, 0.10 g (4 %)
of (2S, 1S)-1v, and 0.07 g (3 %) of diastereomeric mix-
ture. (2S, 1R)-1v: White wax; 49–57 ◦C; TLC (PE/AcOEt
5:1): Rf = 0.41; [α]D = −21.3 (c 0.800, CHCl3); IR
(KBr): 766, 1161, 1202, 1456, 1509, 1668, 1742, 2844,
2962, 3354; 1H NMR (CDCl3, 300 MHz): δ 0.88 (d,
3 J = 6.5, 3H, (CH(CH3)2), 1.10 (d, 3 J = 6.5, 3H,
(C(CH3)′2), 1.14 (s, 3H, CH3), 1.28 (s, 9H, C(CH3)3),
1.69–1.96 (m, 5H, H-3, H′-3, H-4, H′-4, CH(CH3)2), 2.73
(m, 2 J =3 J1 = 9.0, 3 J = 6.5, 1H, H-5), 3.03 (m,
2 J =3 J1 = 9.0, 3 J = 1.5, 1H, H′-5), 3.62 (dd,3 J1 = 7.0,
3 J = 2.5, 1H, H-2), 3.70 (s, 3H, OCH3), 6.92 (bs, 1H,
CONH); 13C NMR (CDCl3, 75 MHz): δ 14.0 (CH3), 18.7,
18.8 (2xCH(CH3)2), 24.9 (C-4), 29.0 (C(CH3)3), 32.2 (C-
3), 35.8 (CH(CH3)2), 47.7 (C-5), 51.0 (C(CH3)3), 52.2
(OCH3), 62.5 (C-2), 70.0 (C-1), 172.5 (CONH), 177.7
(COOCH3); LC/MS: 299 [M+H]+, retention time: 17.9
min; HRMS (ESI+) calcd for C16H30N2O3Na: 321.2154
(M+Na)+ found 321.2157.(2S, 1S)-1v: Colorless oil; TLC
(PE/AcOEt 5:1): Rf = 0.37; [α]D = −39.8(c 0.733,
CHCl3); IR (KBr): 758, 1170, 1199, 1453, 1507, 1670, 1734,
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2876, 2965, 3365; 1H NMR (CDCl3, 300 MHz): δ 0.86
(d, 3 J = 6.5, 3H, (CH(CH3)2), 0.93 (d, 3 J = 6.5, 3H,
(C(CH3)′2), 1.10 (s, 3H, CH3), 1.36 (s, 9H, C(CH3)3), 1.72
(m, 1H, H-4), 1.86 (m, 3H, H-3, H′-4, CH(CH3)2), 2.02 (m,
1H, H′-3) 2.87 (m, 1H, H-5), 3.05 (m, 1H, H′-5), 3.70 (m,
4H, H-2, OCH3), 6.63 (bs, 1H, CONH); 13C NMR (CDCl3,
75 MHz): δ 14.3 (CH3), 18.91, 18.93 (2xCH(CH3)2), 25.3
(C-4), 29.3 (C(CH3)3), 32.8 (C-3), 35.4 (CH(CH3)2), 50.6
(C-5), 51.1 (C(CH3)3), 52.3 (OCH3), 60.2 (C-2), 69.9
(C-1), 172.5 (CONH), 177.7 (COOCH3); LC/MS: 299
[M+H]+, retention time: 15.2 min; HRMS (ESI+) calcd for
C16H30N2O3Na: 321.2154 (M+Na)+ found 321.2149.
Methyl (2S, 1R)- and (2S, 1S)-1-(1-(tert-butylcarbamoyl)-
1-methyl-3-phenyl-1-ethyl)-pyrrolidine-2-carboxylate
(2S, 1R)-1w and (2S, 1S)-1w
From L-proline (1.16 g, 10.08 mmol), phenyl-2-propanone
(1.12 mL, 8.40 mmol) and tert-butyl isocyanide (0.95 mL,
8.40 mmol); FC (gradient: PE/AcOEt 12:1 to 7:1): yield
1.10 g (38 %): 0.38 g (13 %) of major-1w, 0.39 g (13 %)
of minor-1w and 0.33 g (12 %) of diastereomeric mix-
ture. Major-1w: Pale-yellow wax; M.p. 61–68 ◦C; TLC
(PE/AcOEt 5:1): Rf = 0.39; [α]D = −27.5 (c 0.613,
CHCl3); IR (KBr): 703, 764, 1205, 1454, 1509, 1676, 1734,
2874, 2967, 3314; 1H NMR (CDCl3, 300 MHz): δ 1.16 (s,
3H, CH3), 1.32 (s, 9H, C(CH3)3), 1.75–2.00 (m, 4H, H-
3, H′-3, H-4, H′-4), 3.02–3.11 (m, 3H, H-5, 2xCH2), 3.15
(m, 1H, H′-5), 3.39 (dd, 3 J1 = 9.0,3 J2 = 1.0, 1H, H-2),
3.64 (s, 3H, OCH3), 7.16–7.28 (m, 5H, H-Ar), 7.80 (bs, 1H,
CONH); 13C NMR (CDCl3, 75 MHz): δ 21.8 (CH3), 24.9
(C-4), 29.0 (C(CH3)3), 32.0 (C-3), 39.2 (CH2), 48.1 (C-
5), 50.7 (C(CH3)3), 52.4 (OCH3), 60.1 (C-2), 65.6 (C-1),
126.8, 128.4, 131.1, 138.6 (C-Ar), 175.7 (CONH), 178.8
(COOCH3); LC/MS: 347 [M+H]+, retention time: 20.3
min; HRMS (ESI+) calcd for C20H30N2O3Na: 369.2154
(M+Na)+ found 369.2136. Minor-1w: Pale-yellow wax;
M.p. 42–49 ◦C; TLC (PE/AcOEt 5:1): Rf = 0.30; [α]D =
−11.4 (c 0.733, CHCl3); IR (KBr): 704, 768, 1213, 1455,
1514, 1683, 1735, 2872, 2966, 3314; 1H NMR (CDCl3, 300
MHz): δ 1.10 (s, 3H, CH3), 1.37 (s, 9H, C(CH3)3), 1.68–1.94
(m, 3H, H-3, H-4, H′-4), 2.11 (m, 1H, H′-3), 2.67 (d,2 J =
12.5, 1H, CH2), 2.76 (m, 2 J =3 J1 = 8.5,3 J2 = 6.5,
1H, H-5), 2.99 (m, 2H, H′-5, CH2), 3.72 (s, 3H, OCH3),
3.82 (dd, 3 J1 = 9.5,3 J2 = 3.0, 1H, H-2), 7.13–7.25
(m, 5H, H-Ar), 7.30 (bs, 1H, CONH); 13C NMR (CDCl3,
75 MHz): δ 16.2 (CH3), 25.2 (C-4), 29.2 (C(CH3)3),
32.6 (C-3), 44.8 (CH2), 49.3 (C-5), 50.9 (C(CH3)3), 52.5
(OCH3), 55.6 (C-2), 67.0 (C-1), 127.1, 128.3, 131.0, 137.4
(C-Ar), 174.2 (CONH), 177.9 (COOCH3); LC/MS: 347
[M+H]+, retention time: 17.7 min; HRMS (ESI+) calcd for
C20H30N2O3Na: 369.2154 (M+Na)+ found 369.2171.




From L-proline (1.16 g, 10.08 mmol), 3-methyl-2-butanone
(0.90 mL, 8.40 mmol) and tosylmethyl isocyanide (1.64 g,
8.40 mmol); FC (gradient: PE/AcOEt 5:1 to 1:1): yield 1.38
g (40 %): 0.91 g (26 %) of (2S, 1R)-1x, 0.12 g (4 %) of
(2S, 1S)-1x and 0.32 g (10 %) of diastereomeric mixture.
(2S, 1R)-1x: Colorless oil; TLC (PE/AcOEt 3:1): Rf =
0.19; [α]D = −16.1 (c 1.065, CHCl3); IR (KBr): 565, 669,
745, 1142, 1205, 1323, 1506, 1685, 1733, 2876, 2956, 3310;
1H NMR (CDCl3, 300 MHz): δ 0.70 (d, 3 J = 7.0, 3H,
(CH(CH3)2), 1.00 (d, 3 J = 7.0, 3H, CH(CH3)′2), 1.06 (s,
3H, CH3), 1.66–1.89 (m, 2H, H-4, H′-4), 1.90–2.06 (m, 3H,
CH(CH3)2, H-3, H′-3), 2.42 (s, 3H, Ar-CH3), 2.72 (m, 1H,
H-5), 2.91 (m, 1H, H′-5), 3.75 (m, 4H, H-2, OCH3), 4.51
(dd, 2 J = 14.0, 3 J = 6.5, 1H, CH2), 4.80 (dd, 2 J = 14.0,
3 J = 7.5, 1H, CH ′2), 7.33 (d, 3 J = 8.0, 2H, H-Ar), 7.81
(d, 3 J = 8.0, 2H, H-Ar), 8.46 (pt, 3 J = 7.0, 1H, CONH);
13C NMR (CDCl3, 75 MHz): δ 15.9, 17.8, 18.4, 21.8, 24.5,
31.6, 33.9, 47.2 (C-5), 52.6 (OCH3), 61.0, 61.3, 67.9 (C-1),
129.0, 129.9, 135.2, 145.1 (C-Ar), 175.1 (CONH), 178.0
(COOCH3); LC/MS: 411 [M+H]+, retention time: 13.9
min; HRMS (ESI+) calcd for C20H30N2O5SNa: 433.1773
(M+Na)+ found 433.1791.(2S, 1S)-1x: Colorless oil; TLC
(PE/AcOEt 3:1): Rf = 0.13; [α]D = −17.5 (c 0.558,
CHCl3); IR (KBr): 570, 668, 761, 1142, 1320, 1506, 1699,
1733, 2876, 2965, 3418; 1H NMR (CDCl3, 300 MHz): δ
0.73 (d, 3 J = 6.5, 3H, CH(CH3)2), 0.80 (d, 3 J = 6.5,
3H, (C(CH3)′2), 1.06 (s, 3H, CH3), 1.66–2.03 (m, 5H,
CH(CH3)2, H-3, H′-3, H-4, H′-4), 2.43 (s, 3H, Ar-CH3),
2.75 (m, 1H, H-5), 3.05 (m, 1H, H′-5), 3.66 (dd, 3 J1 =
8.5,3 J2 = 3.5, 1H, H-2), 3.71 (s, 3H, OCH3), 4.67 (dd,
2 J = 14.0, 3 J = 6.5, 1H, CH2), 4.82 (dd, 2 J = 14.0,
3 J = 7.5, 1H, CH ′2), 7.35 (d, 3 J = 8.5, 2H, H-Ar), 7.62
(pt, 3 J = 6.5, 1H, CONH), 7.81 (d, 3 J = 8.5, 2H, H-Ar);
13C NMR (CDCl3, 75 MHz): δ 14.8, 18.5, 18.7, 22.2, 25.2,
32.5, 34.9, 50.2 (C-5), 52.5 (OCH3), 60.2, 60.9, 69.7 (C-1),
129.2, 130.3, 135.1, 145.7 (C-Ar), 174.0 (CONH), 177.5
(COOCH3); LC/MS: 411 [M+H]+, retention time: 11.9
min; HRMS (ESI+) calcd for C20H30N2O5SNa: 433.1773
(M+Na)+ found 433.1775.
Methyl (2S, 1R)- and (2S, 1S)-1-(1-(n-butylcarbamoyl)-
1,2-dimethyl-1-propyl)-pyrrolidine-2-carboxylate
(2S, 1R)-1y and (2S, 1S)-1y
From L-proline (0.58 g, 5.04 mmol), 3-methyl-2-butanone
(0.45 mL, 4.20 mmol) and n-butyl isocyanide (0.44 mL,
4.20 mmol); FC (gradient: PE/AcOEt 7:1 to 3:1): yield 0.52 g
(42 %): 0.14 g (11 %) of major-1y, 0.21 g (17 %) of minor-1y
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and 0.18 g (14 %) of diastereomeric mixture. Major-1y: Col-
orless oil; TLC (PE/AcOEt 5:1): Rf = 0.26; [α]D = −38.3
(c 0.853, CHCl3); IR (KBr): 668, 1162, 1205, 1457, 1520,
1671, 1736, 2872, 2958, 3380; 1H NMR (CDCl3, 300 MHz):
δ 0.90 (m, 6H), 1.07 (d, 3 J = 6.5, 3H, (C(CH3)2), 1.18 (s,
3H, CH3), 1.23–1.50 (m, 4H), 1.68-2.00 (m, 5H), 2.74 (m,
2 J =3 J1 = 10.0,3 J2 = 6.5, 1H, H-5), 2.92–3.07 (m, 2H),
3.29 (m, 1H), 3.63 (dd, 3 J1 = 6.5,3 J2 = 3.5, 1H, H-2),
3.67 (s, 3H, OCH3), 7.17 (pt, 3 J = 5.5, 1H, CONH); 13C
NMR (CDCl3, 75 MHz): δ 14.2, 14.5, 18.7, 18.8, 20.8, 24.9,
32.1, 32.2, 35.5, 39.3, 47.7 (C-5), 52.3 (OCH3), 62.2 (C-
2), 69.4 (C-1), 173.7 (CONH), 178.0 (COOCH3); LC/MS:
299 [M+H]+, retention time: 16.4 min; HRMS (ESI+) calcd
for C16H30N2O3Na: 321.2154 (M+Na)+ found 321.2155.
Minor-1y: Pale-yellow oil; TLC (PE/AcOEt 5:1): Rf =0.21;
[α]D = −30.9 (c 0.840, CHCl3); IR (KBr): 758, 1157,
1202, 1457, 1520, 1652, 1734, 2873, 2960, 3366; 1H NMR
(CDCl3, 300 MHz): δ 0.83 (d, 3 J = 6.5, 3H, (C(CH3)2),
0.94 (m, 6H), 1.14 (s, 3H, CH3), 1.36 (m, 2H), 1.49 (m,
2H), 1.80–1.95 (m, 4H), 2.03 (m, 1H), 2.87 (m, 2 J =3 J1 =
9.5,3 J2 = 6.5, 1H, H-5), 3.04 (m, 1H), 3.25 (m, 2H), 3.70
(m, 4H, H-2, OCH3), 6.74 (pt, 3 J = 5.5, 1H, CONH);
13C NMR (CDCl3, 75 MHz): δ 14.2, 14.5, 18.8, 18.9,
20.8, 25.3, 32.4, 32.7, 35.3, 39.4, 50.5 (C-5), 52.3 (OCH3),
60.2 (C-2), 69.8 (C-1), 173.4 (CONH), 177.8 (COOCH3);
LC/MS: 299 [M+H]+, retention time: 13.2 min; HRMS
(ESI+) calcd for C16H30N2O3Na: 321.2154 (M+Na)+ found
321.2163.
Methyl (2S, 1R)- and (2S, 1S)-
1-(1-(tosylmethylcarbamoyl)-1-methyl-1-propyl)-
pyrrolidine-2-carboxylate (2S, 1R)-1z and
(2S, 1S)-1z
From L-proline (1.16 g, 10.08 mmol), 2-butanone (0.75 mL,
8.40 mmol) and tosylmethyl isocyanide (1.64 g, 8.40 mmol);
FC (gradient: PE/AcOEt 4:1 to 1:1): yield 1.06 g (32 %): 0.32
g (10 %) of major-1z, 0.29 g (9 %) of minor-1z and 0.45 g
(13 %) of diastereomeric mixture. Major-1z: Colorless oil;
TLC (PE/AcOEt 3:1): Rf = 0.08; [α]D = −6.7 (c 0.915,
CHCl3); IR (KBr): 557, 671, 766, 1142, 1211, 1321, 1506,
1686, 1734, 2851, 2880, 2928, 3290; 1H NMR (CDCl3, 500
MHz): δ 0.72 (t, 3 J = 7.5, 3H, CH2CH3), 1.07 (s, 3H, CH3),
1.67 (q,3 J = 7.5, 2H, CH2CH3), 1.76–1.87 (m, 2H, H-4, H′-
4), 1.93–2.09 (m, 2H, H-3, H′-3), 2.43 (s, 3H, Ar-CH3), 2.67
(m, 1H, H-5), 2.87 (m, 1H, H′-5), 3.76 (s, 3H, OCH3), 3.85
(dd, 3 J1 = 9.5, 3 J2 = 1.5, 1H, H-2), 4.59 (dd, 2 J = 14.0,
3 J = 6.5, 1H, CH2), 4.77 (dd, 2 J = 14.0, 3 J = 7.5, 1H,
CH ′2), 7.33 (d, 3 J = 8.0, 2H, H-Ar), 7.79 (d, 3 J = 8.0, 2H,
H-Ar), 8.85 (pt, 3 J = 6.5, 1H, CONH); 13C NMR (CDCl3,
125 MHz): δ 7.7, 19.0, 21.8, 24.4, 27.8, 31.3, 47.2 (C-5),
52.4 (OCH3), 60.1, 60.8, 64.2 (C-1), 128.8, 129.7, 134.8,
145.0 (C-Ar), 177.0 (CONH), 177.9 (COOCH3); LC/MS:
411 [M+H]+, retention time: 13.9 min; HRMS (ESI+) calcd
for C19H28N2O5SNa: 419.1617 (M+Na)+ found 419.1605.
Minor-1z: Colorless oil; TLC (PE/AcOEt 3:1): Rf = 0.05;
[α]D = −4.6 (c 1.150, CHCl3); IR (KBr): 760, 1140,
1215, 1321, 1501, 1693, 1732, 2876, 2937, 3337; 1H NMR
(CDCl3, 500 MHz): δ 0.58 (t, 3 J = 7.5, 3H, CH2CH3),
1.05 (s, 3H, CH3), 1.42 (m,3 J = 7.5, 2H, CH2CH3), 1.72
(m, 1H, H-4), 1.78–1.92 (m, 2H, H-3, H′-4), 2.06 (m, 1H,
H′-3), 2.43 (s, 3H, Ar-CH3), 2.66 (m, 1H, H-5), 2.87 (m,
1H, H′-5), 3.68 (dd, 3 J1 = 9.5,3 J2 = 3.5, 1H, H-2), 3.75
(s, 3H, OCH3), 4.70 (dd, 2 J = 14.0, 3 J = 6.5, 1H,
CH2), 4.75 (dd, 2 J = 14.0, 3 J = 6.5, 1H, CH ′2), 7.34
(d, 3 J = 8.0, 2H, H-Ar), 7.80 (d, 3 J = 8.0, 2H, H-Ar),
8.35 (pt, 3 J = 6.5, 1H, CONH); 13C NMR (CDCl3, 125
MHz): δ 9.1, 13.6, 21.7, 24.8, 31.9, 32.0, 48.7 (C-5), 52.3
(OCH3), 58.5, 60.6, 65.7 (C-1), 128.7, 129.9, 134.7, 145.1
(C-Ar), 175.3 (CONH), 177.4 (COOCH3); LC/MS: 411
[M+H]+, retention time: 11.9 min; HRMS (ESI+) calcd for
C19H28N2O5SNa: 419.1617 (M+Na)+ found 419.1597
Methyl (2S, 1R)- and (2S, 1S)-1-(1-(tert-butylcarbamoyl)-
1-methyl-1-propylamino)-3-phenylpropionate (2S, 1R)-4a
and (2S, 1S)-4a
From L-phenylalanine (1.67 g, 10.08 mmol), 2-butanone
(0.75 mL, 8.40 mmol) and tert-butyl isocyanide (0.95 mL,
8.40 mmol); FC (gradient: PE/AcOEt 6:1 to 4:1): yield
1.21 g (43 %) of chromatographically inseparable diastere-
omeric mixture (dr = 50:50, LC/MS). Pale-yellow oil; TLC
(PE/AcOEt 3:1): Rf = 0.38; IR (KBr): 700, 760, 1196,
1454, 1508, 1674, 1740, 2968, 3358; 1H NMR (diastere-
omeric mixture, CDCl3, 500 MHz): δ 0.58 (t, 3 J = 7.5,
3H, CH3I), 0.85 (t, 3 J = 7.5, 3H, CH3II), 1.10 (s, 6H,
CH3I, CH3II), 1.19, 1.29 (2xs, 18H, C(CH3)3I, C(CH3)3II),
1.37–1.55 (m, 2H, CH2CH3II), 1.64 (m, 2H, CH2CH3I)),
1.68 (bs, 1H, NHI), 1.94 (bs, 1H, NHII), 2.78-2.79 (m,3H,
CH2II, CH2’II, CH2I), 2.97 (dd,2 J = 13.5,3 J=6.0, 1H,
CH2’I), 3.42 (pt, 3 J = 7.0, 1H, H-2II), 3.55 (dd, 3 J1 =
8.0,3 J2 = 6.0, 1H, H-2I), 3.62 (s, 3H, OCH3I), 3.67 (s,
3H, OCH3II), 6.95 (bs, 1H, CONHII), 7.16 (m, 4H, H-
Ar), 7.20 (bs, 1H, CONHI), 7.25 (m, 2H, H-Ar), 7.30 (m,
4H, H-Ar); 13C NMR (diastereomeric mixture, CDCl3), 125
MHz): δ 7.9 (CH2CH3I), 8.3 (CH2CH3II), 20.7 (CH3II),
22.4 (CH3I), 28.59, 28.63 (C(CH3)3II, C(CH3)3I), 31.2
(CH2CH3I), 34.2 (CH2CH3II), 41.2 (CH2I), 41.9 (CH2II),
50.1, 50.3 (C(CH3)3II, C(CH3)3I), 51.92, 51.93 (OCH3II,
OCH3I), 57.2 (C-2I), 58.2 (C-2II), 62.4 (C-1II), 62.5 (C-1I),
126.9, 127.0, 128.55, 128.59, 129.33, 129.29, 137.0, 137.1
(C-ArI, C-ArII), 174.5, 174.8 (CONH2I, CONH2II), 176.0,
176.8 (COOCH3I, COOCH3II); LC/MS: 335 [M+H]+,
retention time: 30.7 and 33.1 min; HRMS (ESI+) calcd for
C19H30N2O3Na: 357.2154 (M+Na)+ found 357.2154.
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General procedure for BF•32CH3COOH-mediated
N-detert-butylation/cyclocondensation of
tert-butylamidoesters 1u and 1v
The diastereomeric mixture of the appropriate tert-butyla-
midoester was dissolved in BF•32CH3COOH (∼36 % BF3
basis, 10 mL per 1.5 mmol of the substrate), at 50 ◦C. The
mixture was stirred for 6 h at 50 ◦C and subsequently at rt for
20 h. The resulting solution was slowly poured onto excess of
crushed ice and 25 % aqueous solution of ammonia. The mix-
ture was extracted with DCM (3×40 mL) and DCM/MeOH
3:1 (1×30 mL). The combined organic phase was washed
with water (30 mL), dried over anhydrous MgSO4, filtered
and concentrated under reduced pressure. The residue was
purified by FC.
From the diastereomeric mixture of (2S, 1R)-1u and
(2S, 1S)-1u (490 mg, 1.72 mmol, dr = 86:14, LC/MS) and
BF•32CH3COOH (11 mL); FC (gradient: PE/AcOEt 5:1 to
0:1, then AcOEt/MeOH 9:1 to 5:1): yield 65 %: 105 mg
(31 %) of (4R, 8aS)-3u, 24 mg (7 %) of (4S, 8aS)-3u, 56
mg (17 %) of diastereomeric mixture of (4R, 8aS)-3u and




White wax; M.p. 69–72 ◦C; TLC (AcOEt): Rf = 0.48;
[α]D = −9.4 (c0.583, CHCl3); IR (KBr): 759, 802, 1201,
1456, 1578, 1680, 1731, 2852, 2880, 2936, 2969, 3212,
3340, 3436; 1H NMR (CDCl3, 500 MHz): δ 0.87 (t, 3H,
CH2CH3), 1.20 (s, 3H, CH3), 1.73–1.86 (m, 4H, CH2CH3,
H-4, H′-4), 1.92 (m, 1H, H-3), 2.01 (m, 1H, H′-3), 2.74
(m, 2 J =3 J1 = 6.5,3 J2 = 2.0, 1H, H-5), 3.02 (m,
2 J =3 J1 = 6.5, 3 J2 = 2.0, 1H, H′-5), 3.70 (s, 3H,
OCH3), 3.83 (dd, 3 J1 = 8.0, 3 J2 = 1.5, 1H, H-2), 5.32
(bs, 1H, CONH), 7.65 (bs, 1H, CONH ′);13C NMR (CDCl3,
125 MHz): δ 8.3 (CH2CH3), 17.6 (CH3), 24.5 (C-4), 29.2
(CH2CH3), 31.4 (C-3), 47.3 (C-5), 52.1 (OCH3), 60.4 (C-
2), 64.8 (C-α), 178.0 (COOCH3), 179.4 (CONH); HRMS




White powder; M.p. 71–74 ◦C; TLC (PE/AcOEt 3:1): Rf =
0.33; [α]D = +25.5 (c1.373, CHCl3); IR (KBr): 760, 818,
1234, 1459, 1710, 2826, 2880, 2940, 2974, 3098, 3223; 1H
4 (2S, 1S)-2u could not be isolated from the post-reaction mixture,
most probably due to its full conversion to (4S, 8aS)-3u.
NMR (500 MHz, CDCl3: δ 0.91 (t, 3 J = 7.5, 3H, CH2CH3),
1.31 (s, 3H, CH3), 1.68–1.88 (m, 3H, H-7, H-7′, CH2CH3),
1.94 (m, 3 J = 7.5, 1H, CH2CH′3), 2.20 (m, 2H, H-8, H′-
8), 2.65 (pq, 2 J =3 J1 =3 J2 = 7.5, 1H, H-6), 2.76 (pq,
2 J =3 J1 =3 J2 = 7.5, 1H, H′-6), 3.69 (pt, 3 J = 7.0, 1H,
H-8a), 7.99 (bs, 1H, NH ); 13C NMR (CDCl3, 125 MHz):
δ 7.4 (CH2CH3), 17.9 (CH3), 21.8 (C-7), 26.3 (C-8), 29.1




White powder; M.p. 107–109 ◦C; TLC (PE/AcOEt 3:1):
Rf = 0.23; [α]D = +1.3 (c0.613, CHCl3); IR (KBr): 758,
1251, 1463, 1693, 2814, 2880, 2943, 2943, 2974, 3094,
3219; 1H NMR (500 MHz, CDCl3): δ 0.98 (t, 3 J = 7.5,
3H, CH2CH3), 1.38 (s, 3H, CH3), 1.67–1.91 (m, 4H, H-7,
H′-7, CH2CH3), 2.16–2.31 (m, 2H, H-8, H′-8), 2.46 (pq,
2 J =3 J1 =3 J2 = 8.5, 1H, H-6), 3.11 (m, 2 J =3 J1 = 8.5,
3 J2 = 3.5, 1H, H′-6), 3.95 (dd, 3 J1 = 8.5, 3 J2 = 3.0, 1H,
H-8a), 7.89 (bs, 1H, NH ); 13C NMR (CDCl3, 125 MHz):
δ 7.7 (CH2CH3), 19.5 (CH3), 22.2 (C-7), 27.6 (C-8), 30.4
(CH2CH3), 47.8 (C-6), 59.0 (C-8a), 62.2 (C-4), 174.4 (C-3),
176.2 (C-1); HRMS (ESI-) calcd for C10H15N2O2: 195.1134
(M-H)− found 195.1130.
From the diastereomeric mixture of (2S, 1R)-1v and
(2S, 1S)-1v (338 mg, 1.13 mmol, dr = 21:79, LC/MS) and
BF32CH3COOH (6 mL); FC (gradient: PE/AcOEt 6:1 to
0:1): yield 72 %: 62 mg (26 %) of inseparable diastereomeric
mixture of (4R, 8aS)-3v and (4S, 8aS)-3v(dr = 30:70, 1H
NMR), 33 mg (12 %) of (2S, 1R)-2v and 93 mg (34 %) of
(2S, 1S)-2v.
Methyl (2S, 1R)-1-(1-carbamoyl-1,2-dimethyl-1-propyl)-
pyrrolidine-2-carboxylate and (2S, 1R)-2v
Yellow oil; TLC (AcOEt): Rf = 0.52; [α]D = −26.0 (c
0.845, CHCl3); IR (KBr): 760, 1167, 1211, 1369, 1458,
1509, 1655, 1736, 2852, 296, 3340, 3449; 1H NMR (CDCl3,
300 MHz): δ 0.90 (d, 3 J = 6.5, 3H, (CH(CH3)2), 1.11
(d, 3 J = 6.5, 3H, (C(CH3)′2), 1.19 (s, 3H, CH3), 1.72–
2.07 (m, 5H, H-3, H′-3, H-4, H′-4, CH(CH3)2), 2.77 (m,
2 J =3 J1 = 9.5, 3 J = 6.5, 1H, H-5), 3.05 (m, 1H, H′-5),
3.68 (s, 3H, OCH3), 3.72 (m, 1H, H-2), 5.47 (bs, 1H, CONH)
7.11 (bs, 1H, CONH ′); 13C NMR (CDCl3, 75 MHz): δ
14.3 (CH3), 17.9, 18.3 (2xCH(CH3)2), 24.4 (C-4), 31.6 (C-
3), 34.5 (CH(CH3)2), 47.3 (C-5), 52.0 (OCH3), 61.6 (C-
2), 68.7 (C-1), 176.7 (CONH), 177.7 (COOCH3); HRMS
(ESI+) calcd for C12H22N2O3Na: 265.1528 (M+Na)+ found
265.1532.
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Methyl (2S, 1S)-1-(1-carbamoyl-1,2-dimethyl-1-propyl)-
pyrrolidine-2-carboxylate (2S, 1S)-2v
Pale-yellow wax; M.p. 92–96 ◦C; TLC (AcOEt): Rf =0.42;
[α]D = −35.4 (c 0.813, CHCl3); IR (KBr): 669, 766, 1155,
1202, 1458, 1508, 1541, 1653, 1738, 2876, 2964, 3200;
1H NMR (CDCl3, 300 MHz): δ 0.90 (d, 3 J = 6.5, 3H,
(CH(CH3)2), 0.96 (d, 3 J = 6.5, 3H, (C(CH3)′2), 1.14
(s, 3H, CH3), 1.74 (m, 1H, H-4), 1.86 (m, 2H, H-3, H′-
4), 2.02 (m, 2H, H′-3, CH(CH3)2) 2.93 (m,2 J =3 J1 =
9.5,3 J2 = 7.0, 1H, H-5), 3.12 (m, 2 J = 9.5,3 J1 = 6.5,
3 J2 = 4.5, 1H, H′-5), 3.69 (s, 3H, OCH3), 3.74 (dd,
3 J1 = 9.5,3 J2 = 3.5, 1H, H-2), 5.33 (bs, 1H, CONH),
6.55 (bs, 1H, CONH ′); 13C NMR (CDCl3, 75 MHz): δ
14.1 (CH3), 18.0, 18.4 (2xCH(CH3)2), 24.8 (C-4), 32.0 (C-
3), 34.2 (CH(CH3)2), 49.7 (C-5), 51.8 (OCH3), 59.8 (C-
2), 69.1 (C-1), 175.8 (CONH), 177.3 (COOCH3); HRMS
(ESI+) calcd for C12H22N2O3Na: 265.1528 (M+Na)+ found
265.1533.
General procedure for NaOH-mediated cyclocondensation
of amidoesters 2v and 2x
To a stirred solution of the appropriate amidoester in absolute
EtOH (5 mL per 0.1 mmol of substrate), NaOH (1 eq.)
was added at room temperature. After dissolution of the
hydroxide, the mixture was stirred for additional 10 min
and quenched with saturated aqueous solution of ammonium
chloride (80 mL). The resulting solution was extracted with
DCM (3×25 mL). The combined organic phase was washed
with water (20 mL), dried over anhydrous MgSO4, filtered




From (2S, 1R)-2v (22 mg, 0.09 mmol) and NaOH (4
mg, 1eq.); FC (gradient: PE/AcOEt 4:1 to 2:1): yield 16
mg (86 %). Pale-yellow wax, M.p. 65 = −70 ◦C; TLC
(PE/AcOEt 3:1): Rf = 0.35; [α]D = +3.6 (c0.893, CHCl3);
IR (KBr): 1246, 1373, 1460, 1701, 2851, 2924, 2964, 3101,
3234; 1H NMR (500 MHz, CDCl3): δ 1.08 (d, 3 J = 6.5, 3H,
CH(CH3)2), 1.09 (d, 3 J = 6.5, 3H, CH(CH3)′2), 1.30 (s, 3H,
CH3), 1.64–1.91 (m, 3H, H-7, H-7′, H-8), 2.02–2.25 (m, 2H,
H′-8, (CH(CH3)2), 2.69 (m, 2 J =3 J1 = 8.5, 3 J2 = 7.0,
1H, H-6), 2.77 (m, 2 J =3 J1 = 8.5, 3 J2=5.5, 1H, H′-6),
3.61 (pt, 3 J = 7.5, 1H, H-8a), 7.26 (bs, 1H, NH ); 13C NMR
(CDCl3, 125 MHz): δ 13.8 (CH3), 17.7 (2xCH(CH3)2), 21.9
(C-7), 25.7 (C-8), 34.4 (CH(CH3)2), 45.3 (C-6), 59.1 (C-8a),
65.1 (C-4), 173.1 (C-3), 176.5 (C-1); HRMS (ESI-) calcd for
C11H17N2O2: 209.1290 (M-H)− found 209.1281.
(4S, 8aS)-4-Isopropyl-4-methylperhydropyrrolo[1,2-
a]pyrazine-1,3-dione (4S, 8aS)-3v
From (2S, 1S)-2v (85 mg, 0.35 mmol) and NaOH (14 mg,
1eq.); FC (gradient: PE/AcOEt 4:1 to 2:1): yield 60 mg
(82 %). White wax; M.p. 107–110 ◦C; TLC (PE/AcOEt 3:1):
Rf = 0.32; [α]D = −28.4 (c0.758, CHCl3); IR (KBr):
1261, 392, 1458, 1508, 1541, 1705, 2820, 2920, 2974, 3157;
1H NMR (500 MHz, CDCl3): δ 0.91 (d, 3 J = 6.5, 3H,
CH(CH3)2), 1.01 (d, 3 J = 6.5, 3H, CH(CH3)′2), 1.22 (s,
3H, CH3), 1.75–1.87 (m, 2H, H-7, H′-7), 2.07 (m,3 J = 6.5,
1H, CH(CH3)2), 2.26 (m, 2H, H-8, H′-8), 2.41 (pq, 2 J =3
J1 =3 J2 = 9.0, 1H, H-6), 3.13 (m, 2 J = 9.0, 3 J1=7.5,
3 J2 = 3.5, 1H, H′-6), 3.95 (pt, 3 J1 =3 J2 = 5.5, 1H, H-8a),
7.84 (bs, 1H, NH ); 13C NMR (CDCl3, 125 MHz): δ 13.9
(CH3), 16.1, 17.5 (2xCH(CH3)2), 22.3 (C-7), 28.2 (C-8),
32.6 (CH(CH3)2), 48.2 (C-6), 58.5 (C-8a), 65.4 (C-4), 175.1
(C-3), 175.8 (C-1); HRMS (ESI-) calcd for C11H17N2O2:




From (2S, 1R)-1x (107 mg, 0.26 mmol) and NaOH (10
mg, 1eq.); FC (gradient: PE/AcOEt 8:1 to 3:1): yield 50
mg (68 %). Pale-yellow oil; TLC (PE/AcOEt 5:1): Rf =
0.38; [α]D = +11.1 (c0.717, CHCl3); IR (KBr): 1101,
1242, 1296, 1344, 1373, 1454, 1508, 1693, 1738, 2879,
2930, 2972, 3369; 1H NMR (500 MHz, CDCl3): δ 1.04
(d, 3 J = 7.0, 3H, CH(CH3)2), 1.09 (d, 3 J = 7.0,
3H, CH(CH3)′2), 1.17 (t,3 J = 7.0, 3H, CH2OCH2CH3),
1.29 (s, 3H, CH3), 1.75–1.88 (m, 2H, H-7, H-7′), 2.10–
2.24 (m, 3H, H-8, H′-8, (CH(CH3)2), 2.67 (m, 2 J =3
J1 = 8.5, 3 J2 = 7.0, 1H, H-6), 2.81 (m, 2 J =3
J1 = 8.5, 3 J2 = 5.0, 1H, H′-6), 3.57 (m, 3H, H-8a,
CH2OCH2CH3), 5.19 (d, 2 J = 9.5, 1H, CH2OCH2CH3),
5.23 (d, 2 J = 9.5, 1H, CH2OCH2CH′3); 13C NMR (CDCl3,
125 MHz): δ 13.6 (CH3), 15.1 (CH2OCH2CH3), 17.6, 17.7
(2xCH(CH3)2), 21.9 (C-7), 26.4 (C-8), 35.4 (CH(CH3)2),
45.5 (C-6), 59.0 (C-8a), 65.3 (C-4), 65.8 (CH2OCH2CH3),
69.1 (CH2OCH2CH3), 173.1 (C-3), 176.4 (C-1); HRMS





From (2S, 1S)-1x (85 mg, 0.21 mmol) and NaOH (9 mg,
1eq.); FC (gradient: PE/AcOEt 8:1 to 3:1): yield 31 mg
(56 %). Pale-yellow oil; TLC (PE/AcOEt 5:1): Rf = 0.35;
[α]D = −14.8 (c0.483, CHCl3); IR (KBr): 1095, 1246,
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1342, 1456, 1522, 1541, 1686, 1732, 2808, 2880, 2930, 2974,
3368; 1H NMR (500 MHz, CDCl3): δ 0.85 (d, 3 J = 6.5,
3H, CH(CH3)2), 1.00 (d, 3 J = 6.5, 3H, CH(CH3)′2), 1.17
(t,3 J = 7.0, 3H, CH2OCH2CH3), 1.23 (s, 3H, CH3),
1.75–1.87 (m, 2H, H-7, H′-7), 2.02 (m,3 J = 6.5, 1H,
CH(CH3)2), 2.16 (m, 1H, H-8), 2.37 (m, 1H, H′-8), 2.42
(pq, 2 J =3 J1 =3 J2 = 9.0, 1H, H-6), 3.12 (m, 2 J =
9.0, 3 J1 = 7.5, 3 J2 = 3.5, 1H, H′-6), 3.57 (m, 2H,
CH2OCH2CH3), 4.05 (dd, 3 J1 = 9.0, 3 J2 = 2.5, 1H,
H-8a), 5.15 (d, 2 J = 9.5, 1H, CH2OCH2CH3), 5.30 (d,
2 J = 9.5, 1H, CH2OCH2CH′3); 13C NMR (CDCl3), 125
MHz): δ 14.5 (CH3), 15.2 (CH2OCH2CH3), 16.0, 17.3
(2xCH(CH3)2), 22.7 (C-7), 29.8 (C-8), 32.7 (CH(CH3)2),
48.7 (C-6), 58.8 (C-8a), 65.2 (C-4), 65.5 (CH2OCH2CH3),
68.8 (CH2OCH2CH3), 175.1 (C-3), 175.5 (C-1); HRMS
(ESI+) calcd for C14H24N2O3Na: 291.1685 (M+Na)+ found
291.1677.
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